The medication is injected weekly subcutaneously (under the skin) of the stomach, thigh, or upper arm. All GLP-1 medications have a black box warning about the risks of thyroid cancer (c-cell tumors). You can administer at any time of the day, on the same day each week, with or without meals. Inject subcutaneously in the […]

There is growing evidence that GLP-1 receptor agonists like semaglutide offer cardiovascular benefits, especially for individuals with pre-existing heart conditions. Rybelsus might help lower the chances of serious heart-related issues like heart attacks and strokes. Though not approved semaglutide and weight loss as a weight-loss drug, many users report appetite suppression and weight reduction. This […]